Colossal Biosciences
A Scientist specializing in synthetic biology and genome engineering for species conservation and de-extinction. The role involves developing tools, methodologies, and workflows for manipulating DNA and genomes.
Colossal Biosciences (Colossal) is a biotechnology company that combines genetics, synthetic biology, and commercial discovery to address extinction and biodiversity loss. The company pursues de‑extinction and conservation projects—most publicly known for applying gene editing toward resurrecting the woolly mammoth—and builds genomic platforms and biological tools to support ecosystem restoration and endangered species. Colossal positions itself at the intersection of science and business, partnering with academic and industry collaborators to translate cutting‑edge genomic technologies into conservation outcomes and scalable applications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Colossal Biosciences.
Colossal Biosciences didn’t post a salary, so this is our estimate from similar listings.
Colossal Biosciences Wants to Save the DNA of 10,000 Species
1 month ago